NCT02039817View on ClinicalTrials.gov

PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Renal ImpairmentRenal InsufficiencyKidney DiseaseKidney Diseases
Interventions
DRUG

IDN-6556

Trial Locations (2)

32720

Avail Clinical Research, DeLand

33136

University of Miami, Miami

Sponsors
All Listed Sponsors
lead

Conatus Pharmaceuticals Inc.

INDUSTRY

NCT02039817 - PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers | Biotech Hunter | Biotech Hunter